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ABSORPTION AND RELEASE OF MITOMYCIN-C BY 
“SPONGOSTAN FILM”. 
LARROSA JMl, FERRER J2, PINILLA 11, POLO VI, SANCHEZ 
Al, BUENO J’, HONRUBIA FMl. 
1 Department of Ophthalmology, “Miguel Set-vet” Hospital. 
Zaragoza,(Spain) 
2 Department of Microbiology, 
Puroose: To determine the Mitomycin-C (MMC) 0,4 mg./ml. 
absorption of spumous specimens of “Spongostan Film” (“Sp”) 
and their liberation rate. 
Methods: 1. Physical determination of amount of MMC per volume 
unit that “Sp” is able to absorb. (difference between dry weight 
and soaked weight) 2. Determination of MMC activity in known 
volumes of “Sp” after several times. of antimythotic release. (0, 1, 
10, 30 seconds, I, 3, 5, IO, 15 and 30 minutes). Antibiotic activity 
of specimens is evaluated by mearls of bioassay in E. Coli ATCC 
25922 Agar plates. Milimeters of inhibition of bacterial growth are 
related to pgr. of MMC activity according to a model equation 
obtained from known amounts of MMC. 3. “In viva” determination 
of remaining MMC activity of ‘IO “Sp” after 5 minutes of 
antimythotic release in a filtering surgery in the rabbit 
Results: The MMC maximum capacity of a 25 mm* X 6.5 mm. 
thick “Sp” is 33.96 pgrs.lcm2 (6.49 pgrs.125 mm2 of “Sp”). 
Biologic activity by bioassay is 8.24 pgrs. of MMC for a 25 mm* 
“Sp” (32.96 pgrs/cm2). “In vitro” release of MMC is gradual until 
30 minutes (remaining pgrs.= 0.7!3). MMC “in viva” release by 
“Sp” after 5 minutes is 6.91 micrograms (remaining pgrs.=1.33). 
Conclusions: Bioassay is an easy and sensitive technique that 
permits evaluation of MMC activity. The MMC dosage calculation 
allows comparison among diferenl authors and study of dose- 
effect relationship. 
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MAlNTAlNlNG THE SENSITIVITY TO TIMOLOL WITH A 
“PULSATILE” THERAPY IN PRIMARY OPEN ANGLE 
GLAUCOMA. A 5 YEARS FOLLOW UP. 
VECCHI M. and GANDOLFI S.A, 
Purpose: restormg and mamtammg Ihe sens!tlvlly to the beta 
blockade In glaucoma subjects who developed a longterm drift to 
timolol 
Methods: sensillvlty to the hypolomc effect of l~molol was re.slored 
in 16 pabents, affected by primary open angio glaucoma, chowcng a 
longterm drift This was achieved by performmg a 60 days lastmg 
limclal “holiday” wnth concurrem admmlstratlon of dlplvefrm Then, 
Ihe followmg “pulsatde” schedule was mslored 6 months tlmolol 
0.5% b I d followed by 6 months dlpivc:frm 0 1% b i d A 5 years 
follow up was performed 
&S&S: at the end d the study. 13116 pallems were s1111 retammg a 
good response to tlmolol (IOP < 20 mmHg) 2 pabents here 
withdrawn because of worsenmg of the visual field !n spite ot a 
controlled IOP The rrmatning patlent lost the sensltlviiy IO timolol al 
the bogmnlng of the third year of follow up 
Conclusions. Ihe results suggest tinal alterna(iny a beta birxker 
With an adronerglc agonisl can be effecllve in mamtammg scnsltlvlry 
lo the beta blockade m pabents who previously developed a 
longterm driR 
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